Treatment of psychological and behavioral symptoms in dementia with Lewy bodies and Parkinson’s disease dementia: Literature review and Delphi consensus (notice n° 1573057)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02124cam a2200265 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20251214025814.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Blanc, Frédéric |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Treatment of psychological and behavioral symptoms in dementia with Lewy bodies and Parkinson’s disease dementia: Literature review and Delphi consensus |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 90 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Introduction Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) are frequently associated with psychological and behavioral symptoms (PBSs). Treatment for these symptoms is validated by varying levels of evidence Method We conducted a review of the literature on the treatment of PBSs in DLB and PDD from 2009 to 2023 and formulated treatment recommendations. When evidence from the literature was insufficient, the Delphi method was used to reach a consensus. Results The following recommendations were proposed: for intrusive hallucinations with insight preserved, donepezil or rivastigmine; for delusion and Capgras syndrome (Delphi), low doses of clozapine; for depression, sertraline, venlafaxine, or mirtazapine (Delphi); for REM sleep behavior disorder (RBD), immediate-release melatonin; for frontal syndrome, sertraline or paroxetine first, followed by trazodone (Delphi); for catatonia, lorazepam. Conclusion These recommendations should help improve the management of PBSs in DLB and PDD, thereby enhancing the quality of life of patients and caregivers. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brangier, Antoine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mouton, Aurélie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Magnan, Nathaniel |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rabiant, Kevin |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Auxire, Pauline |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schorr, Benoit |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Roche, Jean |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Soto, Maria |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Delrieu, Julien |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Gériatrie et Psychologie Neuropsychiatrie du Vieillissement | 23 | 2 | 2025-09-20 | p. 235-253 | 2115-8789 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/journal-geriatrie-et-psychologie-neuropsychiatrie-du-vieillissement-2025-2-page-235?lang=en&redirect-ssocas=7080">https://stm.cairn.info/journal-geriatrie-et-psychologie-neuropsychiatrie-du-vieillissement-2025-2-page-235?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux